Carol Moore: Daily

Insightful analysis on how we build, implement, and thrive in a world of change.

CM
Editor
Carol Moore

About This Column

Carol Moore is an expert commentator on the intersection of innovation, strategy, and human impact. Transitioning from her deep dive into healthcare technology, Carol now delivers daily dispatches on the broad trends defining our era—from the ethics of automation to the shifting dynamics of global organizations. With a reputation for analyzing the business and patient-side impacts of change, she offers a unique and grounded perspective on how we can build more efficient, effective systems. Her writing is essential for anyone seeking to understand the "how-to" of the modern world.

Displaying items 21-40 of 981 in total

The Unagentable Blindspot: Why Automated Investigation is the New Frontline for MSPs

Read full article
The Unagentable Blindspot: Why Automated Investigation is the New Frontline for MSPs

Unisync Launches First Share Buyback Amid Microcap Liquidity Challenges

Read full article
Unisync Launches First Share Buyback Amid Microcap Liquidity Challenges

SoftBank Robotics Pivots to Kitchens to Solve Europe's Hospitality Labor Crunch

Read full article
SoftBank Robotics Pivots to Kitchens to Solve Europe's Hospitality Labor Crunch

The End of the Paper Check: AI and Embedded Payments in Insurance

Read full article
The End of the Paper Check: AI and Embedded Payments in Insurance

Scaling AI's Optical Future: Scintil Appoints Romanescu for Mass Production

Read full article
Scaling AI's Optical Future: Scintil Appoints Romanescu for Mass Production

The 78-Hour Day: How Privacy Policies Became the Ultimate Corporate Camouflage

Read full article
The 78-Hour Day: How Privacy Policies Became the Ultimate Corporate Camouflage

Decoding Infleqtion’s 30-Qubit Milestone: A Quantum Growth Signal

Read full article
Decoding Infleqtion’s 30-Qubit Milestone: A Quantum Growth Signal

Plug-and-Play Cell Therapy: BOOST Pharma Takes Aim at Brittle Bone Disease

Read full article
Plug-and-Play Cell Therapy: BOOST Pharma Takes Aim at Brittle Bone Disease

The Death of the Video Quiz: How edX is Rewriting the AI Upskilling Playbook

Read full article
The Death of the Video Quiz: How edX is Rewriting the AI Upskilling Playbook

The Death of the Billable Hour: How Autonomous Agents Are Rewriting Enterprise IT

Read full article
The Death of the Billable Hour: How Autonomous Agents Are Rewriting Enterprise IT

The Intelligence Layer: Why the Next Cleantech Fortune Is Built on Software

Read full article
The Intelligence Layer: Why the Next Cleantech Fortune Is Built on Software

The Amazonification of GovTech: AI Rewires Public Procurement

Read full article
The Amazonification of GovTech: AI Rewires Public Procurement

The Anti-HOA Rebellion: Blue Heron Redefines Luxury Real Estate

Read full article
The Anti-HOA Rebellion: Blue Heron Redefines Luxury Real Estate

The Delaware Drain: HydroGraph's Strategic Shift to U.S. Markets

Read full article
The Delaware Drain: HydroGraph's Strategic Shift to U.S. Markets

A New Weapon Against Amputation: Lakewood-Amedex Advances Resistance-Evading Gel

Read full article
A New Weapon Against Amputation: Lakewood-Amedex Advances Resistance-Evading Gel

How National Giants Are Reshaping Fire Safety in the Pacific Northwest

Read full article
How National Giants Are Reshaping Fire Safety in the Pacific Northwest

Steady Hands in Volatile Waters: FBRT Reinstates Veteran CEO

Read full article
BriefGlance

The Price of Survival: Why Disaster Readiness is Becoming a Luxury

Read full article
The Price of Survival: Why Disaster Readiness is Becoming a Luxury

The Glenlivet's Provençal Gambit: Blending Scottish Craft with French Flair

Read full article
The Glenlivet's Provençal Gambit: Blending Scottish Craft with French Flair

Bayonne's Boom: $68M Loan Fuels New Luxury Waterfront Development

Read full article
Bayonne's Boom: $68M Loan Fuels New Luxury Waterfront Development
UCID: 5